Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound, (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine, is a synthetic small molecule characterized by its pyrrolidine and quinoxaline moieties. While specific biological activity and clinical development information for this exact compound are not readily available in public databases, related pyrrolidine-bearing quinoxaline derivatives have been investigated for their potential as anti-infective agents. These related compounds have shown inhibitory effects on bacterial DNA gyrase, RNA polymerase, and viral spike glycoproteins, suggesting potential antimicrobial, antifungal, and antiviral activities. However, these mechanisms are inferred from the broader class of compounds and are not directly confirmed for this specific chemical entity. It is likely a research compound or a synthetic intermediate rather than a clinically developed drug.
- Other names
- [(3R,4R)-4-amino-1-(quinoxaline-2-carbonyl)pyrrolidin-3-yl]-pyrrolidin-1-ylmethanone
02
Targets
DPP-4 (Dipeptidyl Peptidase-IV)
Beyond the preview
Go deeper on (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine.